BioBridgeXAll companies

Hemoshear Therapeutics, Inc.

Biotechnology company · Charlottesville, Virginia, United States

Hemoshear Therapeutics, Inc. is a biotechnology company headquartered in Charlottesville, Virginia, United States. Its earliest recorded incorporation is in 2008. It has received 16 US government small-business research awards (SBIR/STTR) from health agencies, $18 million in total, most recently in 2017. It has reported private securities offerings to the US SEC, most recently $3.5 million sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

Hemoshear Therapeutics at a glance

Typebiotechnology company
HeadquartersCharlottesville, Virginia, United States
Earliest incorporation on record2008
Employees (self-reported, 2017)25
SEC CIK1442720, 1846099

What does Hemoshear Therapeutics do?

US government research funding

16 SBIR/STTR small-business research awards from US health agencies, $18.1 million in total (2010 to 2017). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences, National Institute of General Medical Sciences.

Private fundraising reported to the SEC

12 Form D notices; the most recent reported $3.5 million sold (2023).

Frequently asked questions about Hemoshear Therapeutics

Where is Hemoshear Therapeutics headquartered?

Hemoshear Therapeutics, Inc. is headquartered in Charlottesville, Virginia, United States.

What does Hemoshear Therapeutics do?

Hemoshear Therapeutics, Inc. is a biotechnology company.

When was Hemoshear Therapeutics founded?

The earliest incorporation on record for Hemoshear Therapeutics, Inc. is in 2008, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-24. Data licences